# Relevance of Plasma PCSK9 Concentration as a Biomarker in Acute Coronary Syndrome.

> **NCT01109706** · — · COMPLETED · sponsor: **Nantes University Hospital** · enrollment: 175 (actual)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **OTHER:** biological parameters dosage

## Key facts

- **NCT ID:** NCT01109706
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02-13
- **Primary completion:** 2013-09-24
- **Final completion:** 2015-07-16
- **Target enrollment:** 175 (ACTUAL)
- **Last updated:** 2021-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01109706

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01109706, "Relevance of Plasma PCSK9 Concentration as a Biomarker in Acute Coronary Syndrome.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01109706. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*